Analyst Recommendations

B. Riley analyst issues UNDERPERFORM recommendation for APEI on March 22, 2024 01:01PM ET. The previous analyst recommendation was Underperform.APEI was trading at $13.665 at issue of the...

March 22, 2024   APEI -2.04%

Barclays analyst issues BUY recommendation for NKTX on March 22, 2024 08:53AM ET. The previous analyst recommendation was Buy.NKTX was trading at $12.98 at issue of the analyst...

March 22, 2024   NKTX 5.88%

Raymond James analyst issues OUTPERFORM recommendation for NKTX on March 22, 2024 08:17AM ET. The previous analyst recommendation was Strong Buy.NKTX was trading at $12.98 at issue of...

March 22, 2024   NKTX 5.88%

EF Hutton analyst issues BUY recommendation for ITI on March 20, 2024 08:00AM ET. The previous analyst recommendation was Buy.ITI was trading at $4.79 at issue of the...

March 20, 2024   NKTX 5.88%

Piper Sandler analyst issues OVERWEIGHT recommendation for IMAB on March 18, 2024 07:52AM ET. The previous analyst recommendation was Overweight.IMAB was trading at $1.75 at issue of the...

March 18, 2024   IMAB 0.30%

JMP Securities analyst issues MARKET OUTPERFORM recommendation for SPRB on March 14, 2024 04:15PM ET. The previous analyst recommendation was Market Outperform.SPRB was trading at $0.8106 at issue...

March 15, 2024   SPRB -5.56%

JMP Securities analyst issues MARKET OUTPERFORM recommendation for SPRB on March 14, 2024 04:15PM ET. The previous analyst recommendation was Market Outperform.SPRB was trading at $0.8106 at issue...

March 14, 2024   SPRB -5.56%

JMP Securities analyst issues MARKET OUTPERFORM recommendation for SPRB on March 14, 2024 04:15PM ET. The previous analyst recommendation was Market Outperform.SPRB was trading at $0.8106 at issue...

March 14, 2024   SPRB -5.56%

JMP Securities analyst issues MARKET OUTPERFORM recommendation for SPRB on March 14, 2024 04:15PM ET. The previous analyst recommendation was Market Outperform.SPRB was trading at $0.8106 at issue...

March 14, 2024   SPRB -5.56%

H.C. Wainwright analyst issues BUY recommendation for CLNN on March 13, 2024 03:00PM ET. The previous analyst recommendation was Buy.CLNN was trading at $0.4397 at issue of the...

March 13, 2024   CLNN -1.14%